Catalyst Wire Dossier Catalyst Wire Dossier

Investigational obesity medication (name not disclosed)

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational obesity medication (name not disclosed), covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity [Phase 3]

See pricing